Award recordCONTRACT

PROGENICS PHARMACEUTICALS INC

PIID 36C24722N0171· VHA· 247-NETWORK CONTRACT OFFICE 7 (36C247)· 6505 · DRUGS AND BIOLOGICALS· FY2022· $5,719,999 net obligations· UEI YLYKVRPCTCR3· MA

Description

FLUORINE 18 PIFLUFOLASTAT - PYLARIFY

First action · last action
2022-03-09 · 2026-04-14
Transactions
11
First transaction's obligation
$245,950
Base + all options value (sum of deltas)
$5,719,999
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
36F79719D0170
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 11 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$5,719,999$0Base award · 2022-03-09 · this action $245,950 · running total $245,950Modification P00001 · 2022-03-18 · this action $0 · running total $245,950Modification P00002 · 2023-01-11 · this action $454,699 · running total $700,649Modification P00003 · 2023-03-17 · this action $631,526 · running total $1,332,175Modification P00004 · 2024-01-02 · this action $451,090 · running total $1,783,265Modification P00005 · 2024-04-10 · this action $1,443,488 · running total $3,226,753Modification P00006 · 2024-06-04 · this action -$140,740 · running total $3,086,013Modification P00007 · 2024-09-12 · this action -$7,027 · running total $3,078,985Modification P00009 · 2025-02-27 · this action $1,984,796 · running total $5,063,781Modification P00008 · 2025-03-12 · this action $505,221 · running total $5,569,002Modification P00010 · 2026-04-14 · this action $150,997 · running total $5,719,999
  • Base2022-03-09+$245,950= $245,950
  • Mod P000012022-03-18+$0= $245,950
  • Mod P000022023-01-11+$454,699= $700,649
  • Mod P000032023-03-17+$631,526= $1,332,175
  • Mod P000042024-01-02+$451,090= $1,783,265
  • Mod P000052024-04-10+$1,443,488= $3,226,753
  • Mod P000062024-06-04-$140,740= $3,086,013
  • Mod P000072024-09-12-$7,027= $3,078,985
  • Mod P000092025-02-27+$1,984,796= $5,063,781
  • Mod P000082025-03-12+$505,221= $5,569,002
  • Mod P000102026-04-14+$150,997= $5,719,999
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2022-03-09+$245,950$245,950FLUORINE 18 PIFLUFOLASTAT - PYLARIFY
Mod P00001· OTHER ADMINISTRATIVE ACTION2022-03-18+$0$245,950FLUORINE 18 PIFLUFOLASTAT - PYLARIFY
Mod P00002· FUNDING ONLY ACTION2023-01-11+$454,699$700,649FLUORINE 18 PIFLUFOLASTAT - PYLARIFY
Mod P00003· EXERCISE AN OPTION2023-03-17+$631,526$1,332,175FLUORINE 18 PIFLUFOLASTAT - PYLARIFY
Mod P00004· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2024-01-02+$451,090$1,783,265FLUORINE 18 PIFLUFOLASTAT - PYLARIFY
Mod P00005· EXERCISE AN OPTION2024-04-10+$1,443,488$3,226,753FLUORINE 18 PIFLUFOLASTAT - PYLARIFY
Mod P00006· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2024-06-04−$140,740$3,086,013FLUORINE 18 PIFLUFOLASTAT - PYLARIFY
Mod P00007· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2024-09-12−$7,027$3,078,985FLUORINE 18 PIFLUFOLASTAT - PYLARIFY
Mod P00009· EXERCISE AN OPTION2025-02-27+$1,984,796$5,063,781FLUORINE 18 PIFLUFOLASTAT - PYLARIFY
Mod P00008· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2025-03-12+$505,221$5,569,002FLUORINE 18 PIFLUFOLASTAT - PYLARIFY
Mod P00010· EXERCISE AN OPTION2026-04-14+$150,997$5,719,999FLUORINE 18 PIFLUFOLASTAT - PYLARIFY

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI YLYKVRPCTCR3)

AwardOffice · PSC / listingNet obligationsFY
36C24626N0890246-NETWORK CONTRACTING OFFICE 6 (36C246) · 6505 · DRUGS AND BIOLOGICALS$1,212,530FY2026
36C24626A0027246-NETWORK CONTRACTING OFFICE 6 (36C246) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36C26226F0313262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS$180,436FY2026
36C25026N0655250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS$721,744FY2026
36C26026F0298260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$469,134FY2026
36C25026N0531250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS$559,352FY2026

Other recipients under 6505 from 247-NETWORK CONTRACT OFFICE 7 (36C247) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C24726P0690SINA DRUG LLC247-NETWORK CONTRACT OFFICE 7 (36C247)$188,463FY2026
36C24726N0211BOSTON SCIENTIFIC CORP247-NETWORK CONTRACT OFFICE 7 (36C247)$248,982FY2026
36C24726F0100AMICUS THERAPEUTICS US, LLC247-NETWORK CONTRACT OFFICE 7 (36C247)$228,396FY2026
36C24726F0053EXELAN PHARMACEUTICALS INC247-NETWORK CONTRACT OFFICE 7 (36C247)$4,765,853FY2026
36C24726F0043AMICUS THERAPEUTICS US, LLC247-NETWORK CONTRACT OFFICE 7 (36C247)$109,456FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24722N0171_3600_36F79719D0170_3600 · retrieved 2026-09-26.